C07D 498/16
Peri-condensed systems
C07D498/16 (Peri-condensed systems) appears on 182 US grants and 246 published applications in this corpus.
Search patents in C07D- Granted patents
- 182
- Published applications
- 246
- Assignees
- 137
- Inventors
- 885
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 6 |
| 2003 | 3 | 3 |
| 2004 | 4 | 6 |
| 2005 | 2 | 2 |
| 2006 | 0 | 1 |
| 2007 | 2 | 6 |
| 2008 | 1 | 2 |
| 2009 | 3 | 6 |
| 2010 | 2 | 10 |
| 2011 | 6 | 8 |
| 2012 | 4 | 6 |
| 2013 | 8 | 15 |
| 2014 | 9 | 16 |
| 2015 | 14 | 16 |
| 2016 | 19 | 16 |
| 2017 | 15 | 16 |
| 2018 | 11 | 9 |
| 2019 | 17 | 9 |
| 2020 | 5 | 14 |
| 2021 | 8 | 11 |
| 2022 | 11 | 14 |
| 2023 | 3 | 11 |
| 2024 | 3 | 18 |
| 2025 | 4 | 18 |
| 2026 | 7 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Materials for organic electroluminescent devices15 Sep 2026US 12,735,436 B2Universal Display Corporation
- Tricyclic derivatives and related uses1 Sep 2026US 12,723,045 B2MOMA Therapeutics, Inc.
- Macrocyclic compounds as STING agonists14 Jul 2026US 12,679,849 B2Lupin Limited
- Substituted heteroaromatic amines and uses thereof30 Jun 2026US 12,668,600 B2Kumquat Biosciences Inc.
- 3-phenylpropylamine derivative21 Apr 2026US 12,606,533 B2Daiichi Sankyo Company, Limited
- Heterocyclic compounds as parp1 inhibitors1 Oct 2026US 2026/0297102 A1Synnovation Therapeutics, Inc.
- Cyclic compounds used as multi-target kinase inhibitors and preparation method therefor24 Sep 2026US 2026/0285873 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Macrocyclic compounds as usp1 inhibitors24 Sep 2026US 2026/0285876 A1Guangdong Newopp Biopharmaceuticals Co., Ltd.
- Fused ring piperidine compound, and preparation method therefor and use thereof6 Aug 2026US 2026/0224590 A1Center for Excellence In Molecular Cell Science, Chinese Academy of Sciences
- Oxazepine compounds comprising a 6-aza moiety and uses thereof21 May 2026US 2026/0137699 A1Genentech, Inc.
Most cited
By later US patents
- Fermentation process of preparing demethyl maytansinoids304US 4,361,650 ATakeda Chemical Industries, Ltd. · 1982
- Demethyl maytansinoids301US 4,307,016 ATakeda Chemical Industries, Ltd. · 1981
- Cytotoxic agents comprising new maytansinoids227US 7,276,497 B2ImmunoGen, Inc. · 2007
- Water soluble rapamycin esters141US 5,780,462 AAmerican Home Products Corporation · 1998
- 27-hydroxyrapamycin and derivatives thereof115US 5,256,790 AAmerican Home Products Corporation · 1993